ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2022
Validity and Reliability of Turkish Version of Chronic Otitis Media Questionaire-12.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disease-specific quality of life scales have garnered prominence in recent years. Chronic Otitis Media Questionnaire-12 (COMQ-12) is a new scale developed for evaluating health-related quality of life in patients with chronic otitis media (COM). This study aimed to investigate the validity and reliability of the Turkish version of COMQ-12. The COMQ-12 was translated into Turkish. The Turkish version was administered to four groups consisting of 35 individuals to assess its validity. Group 1 consisted of healthy individuals, group 2 had patients with inactive COM, group 3 had patients with healed COM and group 4 had patients with active COM. The questionnaire was administered to healthy participants twice to estimate test-retest reliability. The scores of the control group were compared with the others to test the validity of the questionnaire. The test and retest Cronbach's alpha values of the Turkish version of COMQ-12 were 0.918 and 0.917, respectively, which indicates excellent internal consistency. The total and each item scores of the active COM group were significantly higher than the control group (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.